Form 8-K - Current report:
SEC Accession No. 0001193125-25-158806
Filing Date
2025-07-14
Accepted
2025-07-14 17:12:47
Documents
16
Period of Report
2025-07-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d918608d8k.htm   iXBRL 8-K 31463
2 EX-1.1 d918608dex11.htm EX-1.1 192681
3 EX-5.1 d918608dex51.htm EX-5.1 9803
7 GRAPHIC g918608g0714035110928.jpg GRAPHIC 2613
8 GRAPHIC g918608g0714035111665.jpg GRAPHIC 1548
  Complete submission text file 0001193125-25-158806.txt   419719

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA prok-20250714.xsd EX-101.SCH 2856
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE prok-20250714_lab.xml EX-101.LAB 18737
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prok-20250714_pre.xml EX-101.PRE 11711
18 EXTRACTED XBRL INSTANCE DOCUMENT d918608d8k_htm.xml XML 3782
Mailing Address 2000 FRONTIS PLAZA BLVD. SUITE 250 WINSTON-SALEM NC 27103
Business Address 2000 FRONTIS PLAZA BLVD. SUITE 250 WINSTON-SALEM NC 27103 336-999-7028
PROKIDNEY CORP. (Filer) CIK: 0001850270 (see all company filings)

EIN.: 981586514 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40560 | Film No.: 251122407
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)